series-a
Stage
About
Cell-Easy is a contract development and manufacturing organization (CDMO) that produces ready-to-inject adipose-derived allogeneic stem cell products for preclinical and clinical drug development. Its production is optimized under cGMP conditions and has been inspected by the French ANSM to support scalable, regulatory-compliant supply.
Explore Cell-Easy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.